The FDA has approved the expanded indication for EVARREST Fibrin Sealant Patch from Ethicon.
The expand indication allows the patch to be used for the control of bleeding during adult liver surgery. EVARREST is a novel, bioabsorbable hemostat designed to offer hemostatic efficacy, adherence and mechanical strength.
Clinical studies have found the sealant patch to be more than 94 percent effective in controlling bleeding.